CORONAVIRUS/Taiwan's CDC to publish Medigen COVID-19 research in U.S. journal
02/02/2024 09:53 PM
A COVID-19 vaccine research from Taiwan-based Medigen Vaccine Biologics Corp., which found its locally-produced vaccine was as effective as the Moderna and Pfizer BioNTech vaccines, will be featured in a United States medical publication.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
- Taiwan to shorten COVID-19 vaccine interval to 2 months for high-risk groupsThe Centers for Disease Control (CDC) announced Thursday that the required interval between two COVID-19 vaccine doses for high-risk groups will be shortened from six months to two months, effective next Wednesday.06/06/2025 08:17 PM
- CDC confirms ample supply of COVID-19 drugs, vaccinesThe Centers for Disease Control (CDC) reiterated Sunday that Taiwan has sufficient antiviral medication for COVID-19 patients and emphasized the importance of vaccination, amid concerns raised by public figures.06/01/2025 06:13 PM
- CDC issues COVID-19 warning as Dragon Boat Festival long weekend beginsMembers of the public should not let their guard down on COVID-19 and seek medical help if they experience symptoms that indicate risk of severe infection, the Centers for Disease Control (CDC) said Friday, the first day of the Dragon Boat Festival long weekend in Taiwan.05/30/2025 05:04 PM
Latest
- Politics
Taiwan's opposition seeks to abolish Control Yuan
06/13/2025 09:53 PM - Society
Taiwan to see nine extended holidays in 2026
06/13/2025 09:09 PM - Cross-Strait
200 march in Taipei to mark 2019 Hong Kong protest, warn against China
06/13/2025 08:30 PM - Business
'Taiwan Pass' prices to soar on train fare hikes
06/13/2025 07:50 PM - Society
Student killed by falling tree at Taichung's Feng Chia University
06/13/2025 07:20 PM